Cyclosporine nephrotoxicity.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 3546916)

Published in Kidney Int on December 01, 1986

Authors

B D Myers

Associated clinical trials:

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients | NCT00866879

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers | NCT00857844

Articles citing this

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol (2012) 1.71

Acute and chronic renal failure in liver transplantation. Nephron (1990) 1.52

Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol (1990) 0.97

The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation (1992) 0.91

Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol (2003) 0.85

Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients. J Am Soc Nephrol (2008) 0.82

Current status of renal transplantation. West J Med (1990) 0.81

Use of uric acid-lowering agents limits experimental cyclosporine nephropathy. Nephron Exp Nephrol (2011) 0.81

Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A. J Clin Pathol (1994) 0.80

Oscillatory mTOR inhibition and Treg increase in kidney transplantation. Clin Exp Immunol (2015) 0.79

Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol (2010) 0.79

Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats. Inflamm Res (2011) 0.78

Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits. Am J Pathol (1997) 0.78

Cyclosporin C is the main antifungal compound produced by Acremonium luzulae. Appl Environ Microbiol (1997) 0.77

Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats. Int J Exp Pathol (1993) 0.75

Reciprocal regulation of cyclic GMP content by cyclic GMP-phosphodiesterase and guanylate cyclase in SHR with CsA-induced nephrotoxicity. Br J Pharmacol (2001) 0.75

Acute renal failure after cardiac transplantation: a case report and review of the literature. Yale J Biol Med (1997) 0.75

Effect of renal ischemia on plasma levels of FK 506 in rats. Transplant Proc (1992) 0.75

Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function. J Transplant (2011) 0.75

Micophenolat Mofetil versus Azathioprine: effects on renal graft function in early posttransplant period. Bosn J Basic Med Sci (2009) 0.75

Articles by these authors

(truncated to the top 100)

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med (1996) 5.17

Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83

Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76

Cyclosporine-associated chronic nephropathy. N Engl J Med (1984) 3.39

Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int (1985) 2.69

Structural determinants of glomerular permeability. Am J Physiol Renal Physiol (2001) 2.38

Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol (1976) 2.01

Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis (1993) 1.87

Nature of glomerular dysfunction in pre-eclampsia. Kidney Int (1998) 1.81

Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res (1975) 1.69

Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis (1992) 1.46

Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. Am J Physiol (1985) 1.44

Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol (2000) 1.27

Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int (2000) 1.26

Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest (1995) 1.24

Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest (1993) 1.24

PAH extraction and estimation of plasma flow in diseased human kidneys. Am J Physiol (1991) 1.23

Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg (1979) 1.20

Membrano-proliferative glomerulonephritis associated with persistent viral hepatitis. Am J Clin Pathol (1973) 1.16

Effect of gossypol on some oxidative respiratory enzymes. Plant Physiol (1966) 1.14

Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft. J Clin Invest (1998) 1.11

Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol (1979) 1.10

Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med (1980) 1.10

Hemodynamically mediated acute renal failure. N Engl J Med (1986) 1.09

Dynamics of glomerular ultrafiltration in the rat. VIII. Effects of hematocrit. Circ Res (1975) 1.07

Pathophysiology of protracted acute renal failure in man. J Clin Invest (1985) 1.07

PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol (1999) 1.06

Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes (1990) 1.06

Mechanisms and consequences of proteinuria. Lab Invest (1986) 1.05

Relationships among protein and albumin concentrations and oncotic pressure in nephrotic plasma. Am J Physiol (1993) 1.05

Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy. Kidney Int (1980) 1.04

Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest (1982) 1.03

Nature of the glomerular capillary injury in human membranous glomerulopathy. J Clin Invest (1986) 1.02

Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest (1994) 1.01

The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy. Kidney Int (1994) 0.99

Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. J Am Soc Nephrol (1994) 0.98

Glomerular and tubular function in non-oliguric acute renal failure. Am J Med (1982) 0.98

Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int (1992) 0.98

Glomerular permselectivity in healthy and nephrotic humans. Adv Nephrol Necker Hosp (1992) 0.98

Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int (1982) 0.97

Molecular configuration and glomerular size selectivity in healthy and nephrotic humans. Am J Physiol (1997) 0.97

Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int (2000) 0.96

Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol (2008) 0.96

Mechanisms of progressive glomerular injury in membranous nephropathy. J Am Soc Nephrol (1998) 0.94

Functional response of healthy and diseased glomeruli to a large, protein-rich meal. J Clin Invest (1988) 0.94

Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes (1988) 0.94

Imaging and elemental mapping of biological specimens with a dual-EDS dedicated scanning transmission electron microscope. Ultramicroscopy (2013) 0.93

Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease. J Am Soc Nephrol (1993) 0.92

Nature of the renal injury following total renal ischemia in man. J Clin Invest (1984) 0.91

Glomerular function in advanced human diabetic nephropathy. Kidney Int (1982) 0.91

Renal artery blood flow: quantitation with phase-contrast MR imaging with and without breath holding. Radiology (1994) 0.91

Effect of colloid volume expansion on glomerular barrier size-selectivity in humans. Kidney Int (1986) 0.91

Postischemic injury, delayed function and Na+/K(+)-ATPase distribution in the transplanted kidney. Kidney Int (1995) 0.91

Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. Kidney Int (1999) 0.91

Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis (1986) 0.90

Glomerular charge alterations in human minimal change nephropathy. Kidney Int (1982) 0.89

Minimal change nephropathy: an electrochemical disorder of the glomerular membrane. Am J Med (1981) 0.88

Extent and course of glomerular injury in human membranous glomerulopathy. Am J Physiol (1992) 0.88

Pathophysiology and prevention of acute renal failure associated with thoracoabdominal or abdominal aortic surgery. J Vasc Surg (1987) 0.88

Pathophysiology of hemodynamically mediated acute renal failure in man. Kidney Int (1980) 0.88

Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans. Kidney Int (1988) 0.88

Outcome of the acute glomerular injury in proliferative lupus nephritis. J Clin Invest (1989) 0.87

Serum relaxin levels and kidney function in late pregnancy with or without preeclampsia. Clin Nephrol (2011) 0.87

Demonstration of antibodies to deoxyribonucleic acid by counterelectrophoresis. J Immunol (1973) 0.87

Treatment of intractable lupus nephritis with total lymphoid irradiation. Ann Intern Med (1985) 0.87

Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. Am J Physiol (1989) 0.87

Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol (1988) 0.86

The dynamics of glomerular filtration in the puerperium. Am J Physiol Renal Physiol (2003) 0.86

Cyclosporine therapy for autoimmune disease. N Engl J Med (1992) 0.85

Glomerular capillary wall function in human lupus nephritis. Am J Physiol (1984) 0.85

Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am J Physiol (1991) 0.85

Kaposi sarcoma in kidney transplant recipients. Arch Intern Med (1974) 0.85

Course of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Kidney Int Suppl (1997) 0.84

Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephrol (1996) 0.84

Determinants of GFR depression in early membranous nephropathy. Am J Physiol Renal Physiol (2003) 0.83

Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int (1993) 0.83

Changing glomerular filtration with progression from impaired glucose tolerance to Type II diabetes mellitus. Diabetologia (1999) 0.83

Identification of "B" receptor for natriuretic peptide in human kidney. Endocrinology (1992) 0.82

Treatment of lupus nephritis with total lymphoid irradiation. Observations during a 12-79-month followup. Arthritis Rheum (1988) 0.82

Dynamics of glomerular ultrafiltration following open-heart surgery. Kidney Int (1981) 0.81

Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstet Gynecol (2006) 0.81

Filtration dynamics and natriuretic response to volume expansion in humans. Am J Physiol (1992) 0.81

The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology (1984) 0.81

Functional characteristics of the lung in chronic uremia treated by renal dialysis therapy. Chest (1975) 0.81

Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes (1987) 0.80

Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. Am J Surg (2000) 0.80

Course and pathogenesis of postischemic acute renal failure in the rat. Am J Physiol (1988) 0.80

The dynamics of glomerular filtration after Caesarean section. J Am Soc Nephrol (1999) 0.80

Endogenous ANP in postischemic acute renal allograft failure. Am J Physiol (1995) 0.79

The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies. Am J Kidney Dis (1981) 0.79

Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy. Diabetes (1991) 0.79

The pathogenesis and prevention of diabetic glomerulopathy. West J Med (1986) 0.78

Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier. Diabetes (1983) 0.78

Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol (1989) 0.78

Distribution of cell membrane-associated proteins along the human nephron. J Histochem Cytochem (1998) 0.78

Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts. Transplant Proc (1985) 0.78

The aging kidney. Clin Geriatr Med (1985) 0.78

Clinical and pathological course of renal disease in non-insulin-dependent diabetes mellitus: the Pima Indian experience. Semin Nephrol (1997) 0.76

Renal handling of the third (C3) and fourth (C4) components of the complement system in the nephrotic syndrome. Nephron (1976) 0.76

Regulation of platelet clearance receptors for atrial natriuretic peptide in diabetic nephropathy. J Am Soc Nephrol (1992) 0.75